Health Catalyst, Inc. - Common Stock, par value $0.001 per share (HCAT)

Historical Holders from Q3 2019 to Q3 2025

Symbol: HCAT on Nasdaq
Type / Class: Equity / Common Stock, par value $0.001 per share
Shares outstanding: 70,886,873
All holders as of 30 Sep 2025: Q3 2025
Total 13F shares, excl. options: 54,134,701
Holdings value: $154,287,092
% of all portfolios: 0.001%
Number of holders: 141
Number of buys: 72
Number of sells: -72
Average buys %: +0%
Average sells %: -0%

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Significant Owners of Health Catalyst, Inc. - Common Stock, par value $0.001 per share (HCAT)

Filer	Ownership	Change %	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
First Light Asset Management, LLC	19.68%	-0.35%	$41,210,964	-$137,918	13,922,623	-0.33%	Mathew P. Arens	01 Dec 2025
BlackRock, Inc.	6.3%		$17,542,785		4,407,735		BlackRock, Inc.	31 Mar 2025
VANGUARD GROUP INC	5.88%		$16,443,979		4,131,653		The Vanguard Group	31 Mar 2025
Stoney Lonesome HF LP	5.5%		$11,540,383		3,898,778		COGHILL CLINT D	15 Dec 2025
Whetstone Capital Advisors, LLC	5.4%		$10,559,720		3,731,350		Whetstone Capital Advisors, LLC	30 Jun 2025

Institutional Holders of Health Catalyst, Inc. - Common Stock, par value $0.001 per share (HCAT)

Period	Reported Shares, Excl. Options	Value, Excl. Options	Change	Puts Notional Value	Calls Notional Value	Price	Investors
2025 Q3	54,134,701	$154,287,092	-$4,603,372	$912,618	$57,000	$2.85	141
2025 Q2	54,164,187	$204,239,601	+$2,031,442	$601,434	$0	$3.77	144
2025 Q1	53,179,756	$240,899,632	-$15,089,868	$98,754	$2,047,723	$4.53	163
2024 Q4	51,714,283	$365,529,299	+$10,713,924	$113,827	$20,995,072	$7.07	164
2024 Q3	52,033,442	$423,157,153	+$11,669,218	$459,096	$23,292,610	$8.14	158
2024 Q2	50,973,377	$325,694,724	+$3,633,936	$11,502	$16,045,929	$6.39	159
2024 Q1	50,065,423	$376,991,717	+$764,949	$81,324	$18,942,468	$7.53	170
2023 Q4	49,726,125	$460,463,313	+$1,604,271	$6,482	$51,856	$9.26	165
2023 Q3	49,374,836	$499,663,628	+$2,966,722	$174,063	$208,472	$10.12	155
2023 Q2	48,824,578	$610,231,678	+$4,102,989	$98,750	$192,500	$12.5	152
2023 Q1	48,547,295	$566,456,324	-$1,965,202	$44,346	$246,237	$11.67	158
2022 Q4	48,846,831	$519,237,991	-$2,727,981	$40,394	$154,135	$10.63	164
2022 Q3	49,010,406	$475,542,822	-$73,165,265	$748,000	$1,809,000	$9.7	163
2022 Q2	52,853,537	$766,547,805	-$46,880,972	$1,011,000	$164,000	$14.49	170
2022 Q1	53,285,286	$1,391,839,063	-$65,374,738	$1,437,000	$1,952,000	$26.13	180
2021 Q4	55,189,855	$2,186,203,412	+$48,206,866	$2,555,000	$4,391,000	$39.62	178
2021 Q3	53,304,379	$2,668,051,943	+$252,469,889	$3,635,000	$13,838,000	$50.01	198
2021 Q2	48,146,470	$2,673,141,898	+$252,885,500	$4,819,000	$29,453,000	$55.51	197
2021 Q1	43,869,916	$2,051,715,173	+$163,395,411	$4,550,000	$11,735,000	$46.77	187
2020 Q4	40,380,352	$1,757,762,073	+$87,929,967	$548,000	$8,358,000	$43.53	168
2020 Q3	40,018,208	$1,463,894,335	+$230,365,790	$1,735,000	$4,403,000	$36.6	138
2020 Q2	33,977,864	$991,115,334	+$212,900,758	$790,000	$2,365,000	$29.17	127
2020 Q1	27,081,811	$708,117,425	+$93,437,343		$1,766,000	$26.15	107
2019 Q4	23,424,591	$810,679,210	+$30,418,007		$909,000	$34.7	87
2019 Q3	16,697,494	$523,337,673	+$523,337,674			$31.64	85